Advertisement

Topics

#VisualAbstract: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

06:00 EST 11 Jan 2019 | 2 Minute Medicine

1. After a median follow-up of 4.9 years, patients with elevated triglyceride levels despite statin use treated with icosapent ethyl had a lower risk of cardiovascular adverse events compared to patients in a placebo group. 2. Hospitalization for atrial fibrillation or flutter occurred in more patients treated with icosapent ethyl compared to those in the […]
Source: 2 Minute Medicine

Original Article: #VisualAbstract: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

NEXT ARTICLE

More From BioPortfolio on "#VisualAbstract: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...